Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial
Format: | Article |
---|---|
Language: | English |
Published: |
Endocrinology Research Centre
2008-12-01
|
Series: | Ожирение и метаболизм |
Online Access: | https://www.omet-endojournals.ru/jour/article/view/5236 |